Treatment Initiation among Patients with Multidrug Resistant Tuberculosis in Bhopal District, India  

作　　者：Hemant Deepak Shewade Arun M. Kokane Akash Ranjan Singh Manoj Verma Malik Parmar Sanjay Singh Chahar Manoj Tiwari Sheeba Naz Khan Mukesh Nagar Sanjai Kumar Singh Pradeep Kumar Mehra Ajay M. V. Kumar 

机构地区：[1]International Union against Tuberculosis and Lung Disease (The Union), South-East Asia Office, New Delhi, India [2]Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences (AIIMS), Bhopal, India [3]State TB cell, Department of Health and Family Welfare, Bhopal, India [4]World Health Organization, Country Office in India, New Delhi, India [5]International Union against Tuberculosis and Lung Disease (The Union), Paris, France

出　　处：《Journal of Tuberculosis Research》2017年第4期237-242,共6页结核病研究（英文）

摘　　要：Revised national tuberculosis control programme in India has limited co-hort-wise information about what happens to patients diagnosed with multidrug resistant TB (MDR-TB). We determined the pre-treatment loss to follow-up (non-initiation of treatment by programme within 6 months of diagnosis) and time from diagnosis to treatment initiation in Bhopal district, central India (2014). Pre-treatment loss to follow-up was 13% (0.95 CI: 7%, 23%), not significantly different from the national estimates (18%) and median time to initiate treatment was seven days, lower than that reported elsewhere in the country. Bhopal was performing well with reference to time to treatment initiation in programmatic settings.Revised national tuberculosis control programme in India has limited co-hort-wise information about what happens to patients diagnosed with multidrug resistant TB (MDR-TB). We determined the pre-treatment loss to follow-up (non-initiation of treatment by programme within 6 months of diagnosis) and time from diagnosis to treatment initiation in Bhopal district, central India (2014). Pre-treatment loss to follow-up was 13% (0.95 CI: 7%, 23%), not significantly different from the national estimates (18%) and median time to initiate treatment was seven days, lower than that reported elsewhere in the country. Bhopal was performing well with reference to time to treatment initiation in programmatic settings.

关 键 词：MULTIDRUG-RESISTANT TUBERCULOSIS Operational Research Pre-Treatment Attrition Diagnosis and TREATMENT Pathway Initial Loss to FOLLOW-UP 

分 类 号：R5[医药卫生—内科学]